| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2039 |
| Trial ID | NCT03790891 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell|CAR-T cell |
| Treatment | CD19-TriCAR-SILK |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy |
| Year | 2019 |
| Country | China |
| Company sponsor | Timmune Biotech Inc. |
| Other ID(s) | 2018-127 |
| Cohort1: T cell | |||||||||
|
|||||||||
| Cohort2: NK cell | |||||||||
|
|||||||||